JPMorgan Chase & Co’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.7M | Buy |
+313,945
| New | +$1.7M | ﹤0.01% | 3432 |
|
|
2024
Q2 | – | Sell |
-93,038
| Closed | -$282K | – | 6337 |
|
|
2024
Q1 | $282K | Buy |
93,038
+21,730
| +30% | +$65.8K | ﹤0.01% | 4272 |
|
|
2023
Q4 | $300K | Buy |
71,308
+29,459
| +70% | +$124K | ﹤0.01% | 4178 |
|
|
2023
Q3 | $286K | Buy |
41,849
+31,882
| +320% | +$218K | ﹤0.01% | 4020 |
|
|
2023
Q2 | $104K | Buy |
+9,967
| New | +$104K | ﹤0.01% | 4611 |
|
|
2023
Q1 | – | Sell |
-418
| Closed | -$3K | – | 5847 |
|
|
2022
Q4 | $3K | Sell |
418
-10,955
| -96% | -$78.6K | ﹤0.01% | 5296 |
|
|
2022
Q3 | $90K | Sell |
11,373
-126,856
| -92% | -$1M | ﹤0.01% | 4499 |
|
|
2022
Q2 | $1.88M | Buy |
138,229
+115,412
| +506% | +$1.57M | ﹤0.01% | 3056 |
|
|
2022
Q1 | $448K | Buy |
22,817
+6,016
| +36% | +$118K | ﹤0.01% | 4062 |
|
|
2021
Q4 | $576K | Buy |
16,801
+6,085
| +57% | +$209K | ﹤0.01% | 3982 |
|
|
2021
Q3 | $585K | Buy |
10,716
+810
| +8% | +$44.2K | ﹤0.01% | 3888 |
|
|
2021
Q2 | $728K | Sell |
9,906
-34,695
| -78% | -$2.55M | ﹤0.01% | 3806 |
|
|
2021
Q1 | $4.08M | Buy |
44,601
+36,947
| +483% | +$3.38M | ﹤0.01% | 2785 |
|
|
2020
Q4 | $621K | Buy |
+7,654
| New | +$621K | ﹤0.01% | 3640 |
|